Table 11.1.
Screening for selected complications of chronic kidney disease
| Complication | Physical and laboratory evaluation | 
|---|---|
| Blood pressure >130/80 mmHg | Blood pressure, weight, BMI | 
| Volume overload | History, physical examination, weight | 
| Electrolyte abnormalities | Serum electrolytes | 
| Metabolic acidosis | Serum electrolytes | 
| Anemia | Hemoglobin; iron, iron saturation, ferritin testing if indicated | 
| Metabolic bone disease | Serum calcium, phosphate, PTH, vitamin 25(OH)D | 
Complications of chronic kidney disease (CKD) generally become prevalent when estimated glomerular filtration rate falls below 60 mL/min/1.73 m2 (stage G3 CKD or greater) and become more common and severe as CKD progresses. Evaluation of elevated blood pressure and volume overload should occur at every clinical contact possible; laboratory evaluations are generally indicated every 6–12 months for stage G3 CKD, every 3–5 months for stage G4 CKD, and every 1–3 months for stage G5 CKD, or as indicated to evaluate symptoms or changes in therapy. PTH, parathyroid hormone; 25(OH)D, 25-hydroxyvitamin D.